Auto-injectors Global Market Report 2022: Adoption of Inorganic Growth Strategies Such as Product Launches Fuels Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Auto-injectors Market, by Product Type, by Disease Indication, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.

This report provides an in-depth analysis of the global auto-injectors market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year

The injectable delivery enhances the rapid absorption of a drug from various sites such as subcutaneous, intravenous, and intramuscular. The injectable delivery increases the bioavailability of the drug at the systemic circulation, which offers availability of drug at intended site of action.

Epinephrine auto-injector is a type of auto-injector widely used for people at risk of anaphylaxis. Auto-injectors enclose prefilled syringes or cartridges which are driven by a spring system. Auto-injectors are often used in the military to protect personnel from chemical warfare agents.

Market Dynamics

Adoption of inorganic growth strategies such as product launches by key market players is expected to drive the global auto-injectors market over the forecast period.

For instance, in April 2020, Teva Pharmaceutical Industries Ltd., a pharmaceutical company, announced that they had launched auto-injector for AJOVY, which is indicated for the preventive treatment of migraine in adults. This new auto-injector has several features such as easy handling including a button-free, push-down mechanism, audible cues that signal progress of administration, and a window that displays when the dose has been delivered.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global auto-injectors market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global auto-injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global auto-injectors market

Detailed Segmentation:

Global Auto-injectors Market, By Product Type:

• Prefilled Auto-injectors
• Fillable Auto-injectors

Global Auto-injectors Market, By Disease Indication:

• Anaphylaxis
• Multiple Sclerosis
• Rheumatoid Arthritis
• Others (Diabetes, Psoriasis, etc.)

Global Auto-injectors Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Auto-injectors Market, By Region:

• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa

Company Profiles

• Becton, Dickinson and Company
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited
• Xeris Biopharma Holdings Inc.
• BlackHagen Design
• GSK plc.
• Genentech, Inc.
• AstraZeneca
• Owen Mumford Ltd.
• Stevanato Group
• Jabil Inc.
• Pfizer, Inc.
• Mylan N.V.
• Novartis AG
• Bayer AG
• Janssen Pharmaceuticals, Inc.
• Antares Pharma
• Eli Lilly and Company
• Amgen, Inc.
• Rafa Laboratories Ltd.
• Halozyme, Inc.
• Biogen
• Teva Pharmaceutical Industries Ltd.

Key Topics Covered:

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Auto-injectors Market- Impact of Coronavirus (Covid-19) Pandemic

5. Global Auto-injectors Market, By Product Type, 2017 – 2030, (US$ Million)

6. Global Auto-injectors Market, By Disease Indication, 2017 – 2030, (US$ Million)

7. Global Auto-injectors Market, By Distribution Channel, 2017 – 2030, (US$ Million)

8. Global Auto-injectors Market, By Region, 2017 – 2030, (US$ Million)

9. Competitive Landscape

10. Section

For more information about this report visit https://www.researchandmarkets.com/r/bh50k1

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900